An Investigation of PS-b-PEO Polymersomes for the Oral Treatment and Diagnosis of Hyperammonemia.
Sign Up to like & getrecommendations! Published in 2019 at "Small"
DOI: 10.1002/smll.201902347
Abstract: Ammonia-scavenging transmembrane pH-gradient poly(styrene)-b-poly(ethylene oxide) polymersomes are investigated for the oral treatment and diagnosis of hyperammonemia, a condition associated with serious neurologic complications in patients with liver disease as well as in infants with urea… read more here.
Keywords: oral treatment; treatment diagnosis; diagnosis hyperammonemia;
Oral treatment of glucocorticoidâinduced diabetes mellitus: A systematic review
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Clinical Practice"
DOI: 10.1111/ijcp.13529
Abstract: Glucocorticoid-induced diabetes mellitus (GIDM) is a well-known and common metabolic side effect of glucocorticoid (GC) treatment. The risk of developing GIDM in non-diabetic patients who receive systemic GCs, was evaluated in a metanalysis and found… read more here.
Keywords: oral treatment; glucocorticoid induced; treatment; glucocorticoid ... See more keywords
GC-072, a Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens
Sign Up to like & getrecommendations! Published in 2019 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00834-19
Abstract: Burkholderia pseudomallei, the etiological agent of melioidosis, is a Gram-negative bacterium with additional concern as a biothreat pathogen. The mortality rate from B. pseudomallei varies depending on the type of infection and extent of available… read more here.
Keywords: treatment; biothreat; phase treatment; melioidosis ... See more keywords